MHY884 is a tyrosinase inhibitor that suppresses UVB-induced activation of the NF-κB signaling pathway by downregulating oxidative stress; it inhibits oxidative stress in melanoma cells and alleviates UVB-induced oxidative stress in irradiated mice, thereby reducing NF-κB activity; it shows potential for research on UVB-induced skin damage.